Clinical trial
Diabetes and COVID-19 in Tunisia (CoviDTUN)
NCT05603130 is registered in ClinicalTrials.gov with Les Laboratoires des Médicaments Stériles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diabetes and COVID-19 in Tunisia (CoviDTUN)
- Lead sponsor
- Les Laboratoires des Médicaments Stériles
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 23, 2022
- Completion date
- October 17, 2022
- Enrollment
- 811 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19 disease